ImmunityBio releases preliminary 2025 financial results

Go back to ImmunityBio releases preliminary 2025 financial results
(NASDAQ: IBRX) Delayed: 8.13 +0.41 (5.31%)
Previous Close $7.72    52 Week High
Open $8.08    52 Week Low
Day High $8.27    P/E N/A 
Day Low $7.94    EPS
Volume 13,058,857